Navigation Links
Compounds Found to Protect Rabbits From Cerebral Palsy
Date:2/25/2009

Discovery called exciting, but human application remains elusive, expert says

WEDNESDAY, Feb. 25 (HealthDay News) -- In experiments with rabbits, a team of scientists has created two chemical compounds that appear to protect a fetus from developing cerebral palsy from a lack of oxygen.

"It is known that if you have too much nitric oxide in the brain, which can be produced during hypoxia, it leads to fetal neurodegeneration," said lead researcher Richard B. Silverman, a chemistry professor at Northwestern University.

If such an event occurs during pregnancy, it can lead to brain damage in the fetus that can result in cerebral palsy, Silverman said. "This can happen right at the end of pregnancy," he explained.

Common causes of hypoxia include a pinched umbilical cord or a cord wrapped around the fetus's neck or shoulder.

The report was published online Wednesday in the Annals of Neurology.

Silverman's team developed two compounds that block an enzyme in brain cells that produces nitric oxide. At normal levels, nitric oxide is a neurotransmitter, which is important for brain functioning, but at high levels it can damage brain tissue. An excess of nitric oxide in the brain is believed to play a role in cerebral palsy.

In experiments with rabbits, excess nitric oxide caused most of the fetuses to die, and those that survived were severely brain-damaged, Silverman said.

"If you administer the compounds that we made a half-hour prior to the hypoxic insult, you can protect the fetus from neurodegeneration," Silverman said. All the animals treated with the compounds lived, and those given placebo died. Among animals given just one of the compounds, up to 80 percent were born normal, Silverman said.

Silverman said that he thinks the compounds can be used to treat infants with compromised oxygen levels before cesarean delivery. "The sooner you can protect the fetal brain from nitric oxide, the less neurodegeneration you will have," he said.

The next step is to experiment with these compounds in sheep, Silverman said. "It's a long way to humans," he noted.

Dr. Ernest Graham, an assistant professor of maternal-fetal medicine at Johns Hopkins School of Medicine in Baltimore, agrees that using the compounds in clinical practice is a long way off.

"This is very exciting stuff," Graham said. However, he added, how it could be used remains elusive.

Graham said that perhaps the compounds could be used after delivery for infants who appear lethargic or "floppy," or have poor muscle tone, he said. Giving it before delivery would mean giving it to many babies who don't need it, he noted.

Using it before delivery on an infant with a prolapsed cord or similar problem might not be practical, Silverman said. "With these kids, things are moving so fast, I don't know it is going to be practical to give an additional drug," he said.

Cerebral palsy is caused by an injury to the brain before, during or shortly after birth, although it typically is not diagnosed until after the age of 1. Approximately 750,000 children and adults in the United States have a form of cerebral palsy, with most having been born with the condition.

More information

The U.S. National Institute of Neurological Disorders and Stroke has more on cerebral palsy.



SOURCES: Richard B. Silverman, Ph.D., John Evans Professor of Chemistry, Northwestern University, Evanston, Ill.; Ernest Graham, M.D., assistant professor, maternal-fetal medicine, Johns Hopkins School of Medicine, Baltimore; February 2009, Annals of Neurology


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Compounds that trigger beta cell replication identified by JDRF funded researchers
2. Stunning finding: Compounds protect against cerebral palsy
3. AstraZeneca Licenses Novel Antidepressant Compounds Discovered by Mayo Clinic and Virginia Tech Collaboration
4. New platinum-phosphate compounds kill ovarian cancer cells
5. Scientists exploring new compounds to target muscular dystrophy
6. University of Illinois - Chicago Study: Raisins Contain Compounds that May Inhibit Cavity-causing Bacteria
7. InNexus Biotechnology Announces Third Antibody and Expands Pipeline of Anticancer Compounds
8. USPTO Issues Patent Embodying Methodologies for Abating a Broad Range of Allergens, Pathogens, Viruses, Bacteria, Odors and Volatile Organic Compounds.
9. Study Finds Spice-Rich Marinades Can Reduce Harmful Compounds When Grilling
10. ChromaDex Licenses Green Chemistry Technology to Manufacture a New Class of Super Fruit Compounds
11. Drugs With Marijuana Compounds Dont Boost Adverse Events
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... ... January 18, 2017 , ... The VA Maryland ... collaborating on a research project focused on multiple sclerosis (MS). Led by Christopher ... nanotechnology to control the disease without compromising normal immune function that often occurs ...
(Date:1/18/2017)... West Palm Beach, FL (PRWEB) , ... January 18, 2017 , ... ... April as a fund raiser for Smile Train, an international charity that provides free ... is a hobby of mine and in the past I have run to support ...
(Date:1/18/2017)... ... January 18, 2017 , ... At Hallmark Nameplate, their commitment to quality ... achieved certification to ISO 13485. This certification is another way they are making constant ... and services that they need. , The ISO 13485 Certification is a major accomplishment ...
(Date:1/18/2017)... ... January 18, 2017 , ... The Hear the ... project with the donation of cochlear implants. In February 2017, the first three ... a fair chance of leading an independent life. This engagement builds on the ...
(Date:1/17/2017)... , ... January 17, 2017 , ... January is National Stalking Awareness Month ... to lurk in the corners and commit the crime of stalking, a very real danger ... addiction, an often overlooked factor in stalking and other crimes. , “Stalking: know it. Name ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... , Jan. 18, 2017  Eisai Inc., ... announced today that it is participating in Access ... non-communicable diseases (NCDs) prevention, treatment and care in ... Accelerated is the first multi-stakeholder, international initiative in ... pharmaceutical companies, including Eisai, in collaboration with the ...
(Date:1/18/2017)... NEW YORK , January 18, 2017 ... perception of people regarding the use of cannabis both for ... not only are more Americans open to the use of ... and financial sectors. According to Arcview Market Research, the North ... 2016, up 30% from the previous year. The research projects ...
(Date:1/17/2017)... Jan. 17, 2017 Precision medicine is ... the treatment of disease. The approach allows doctors ... a therapy. The approach studies the individual profile ... and environment. In January 2015, Precision Medicine Initiative ... all diseases with more than one million volunteers. ...
Breaking Medicine Technology: